标题
Teriparatide for osteoporosis: importance of the full course
作者
关键词
Bone histomorphometry, Fracture, Osteoporosis, Teriparatide
出版物
OSTEOPOROSIS INTERNATIONAL
Volume 27, Issue 8, Pages 2395-2410
出版商
Springer Nature
发表日期
2016-02-22
DOI
10.1007/s00198-016-3534-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Co-administration of Antiresorptive and Anabolic Agents: A Missed Opportunity
- (2015) Ego Seeman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Daily or Cyclical Teriparatide Treatment in Women With Osteoporosis on no Prior Therapy and Women on Alendronate
- (2015) Felicia Cosman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Teriparatide fracture effectiveness in the real world
- (2015) J. H. Krege et al. OSTEOPOROSIS INTERNATIONAL
- Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis
- (2015) M. M. Bonafede et al. OSTEOPOROSIS INTERNATIONAL
- Anabolic effects of PTH and the ‘anabolic window’
- (2015) Michael Pazianas TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Challenges in longitudinal measurements with HR-pQCT: Evaluation of a 3D registration method to improve bone microarchitecture and strength measurement reproducibility
- (2014) Rafaa Ellouz et al. BONE
- Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis
- (2014) Erik F. Eriksen et al. BONE
- Cortical Bone: A Challenging Geography
- (2014) Roger Zebaze et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
- (2014) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High-resolution in vivo imaging of bone and joints: a window to microarchitecture
- (2014) Piet Geusens et al. Nature Reviews Rheumatology
- Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study
- (2014) C. Senn et al. OSTEOPOROSIS INTERNATIONAL
- Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy
- (2014) B. Hofstetter et al. OSTEOPOROSIS INTERNATIONAL
- PINP as a biological response marker during teriparatide treatment for osteoporosis
- (2014) J. H. Krege et al. OSTEOPOROSIS INTERNATIONAL
- Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment
- (2013) Yanfei L. Ma et al. BONE
- Teriparatide Treatment of Severe Osteoporosis Reduces the Risk of Vertebral Fractures Compared with Standard Care in Routine Clinical Practice
- (2013) Ailsa J. Oswald et al. CALCIFIED TISSUE INTERNATIONAL
- 18F-fluoride Positron Emission Tomography Measurements of Regional Bone Formation in Hemodialysis Patients with Suspected Adynamic Bone Disease
- (2013) Michelle L. Frost et al. CALCIFIED TISSUE INTERNATIONAL
- Teriparatide for Idiopathic Osteoporosis in Premenopausal Women: A Pilot Study
- (2013) Adi Cohen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) study: 2-year nonvertebral fragility fracture results
- (2013) S. Silverman et al. OSTEOPOROSIS INTERNATIONAL
- The US postmarketing surveillance study of adult osteosarcoma and teriparatide: Study design and findings from the first 7 years
- (2012) Elizabeth B Andrews et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee
- (2012) David W Dempster et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: An 18-month open-labeled observational study using HR-pQCT
- (2012) Stinus Hansen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Skeletal Histomorphometry in Subjects on Teriparatide or Zoledronic Acid Therapy (SHOTZ) Study: A Randomized Controlled Trial
- (2012) David W. Dempster et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges
- (2012) D. Bauer et al. OSTEOPOROSIS INTERNATIONAL
- Concise Review: The Periosteum: Tapping into a Reservoir of Clinically Useful Progenitor Cells
- (2012) Hana Chang et al. Stem Cells Translational Medicine
- Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis
- (2011) JH Krege et al. BONE
- The impact of teriparatide adherence and persistence on fracture outcomes
- (2011) S. Yu et al. OSTEOPOROSIS INTERNATIONAL
- Targeted Regeneration of Bone in the Osteoporotic Human Femur
- (2011) Kenneth E. S. Poole et al. PLoS One
- Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases
- (2010) Akimitsu Miyauchi et al. BONE
- Changes in Cross-Sectional Area of Spinal Canal and Vertebral Body Under 2 Years of Teriparatide Treatment: Results from the EUROFORS Study
- (2010) R. Schnell et al. CALCIFIED TISSUE INTERNATIONAL
- Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis
- (2010) Joel S. Finkelstein et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis
- (2010) J. J. Stepan et al. OSTEOPOROSIS INTERNATIONAL
- Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)
- (2010) A. Fahrleitner-Pammer et al. OSTEOPOROSIS INTERNATIONAL
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
- (2010) S. Vasikaran et al. OSTEOPOROSIS INTERNATIONAL
- Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis
- (2010) H. M. Macdonald et al. OSTEOPOROSIS INTERNATIONAL
- Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial
- (2009) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- Rapid and robust response of biochemical markers of bone formation to teriparatide therapy
- (2009) Sarah J. Glover et al. BONE
- Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS)
- (2009) Bente L. Langdahl et al. CALCIFIED TISSUE INTERNATIONAL
- Teriparatide vertebral fracture risk reduction determined by quantitative and qualitative radiographic assessment
- (2009) Sven Prevrhal et al. CURRENT MEDICAL RESEARCH AND OPINION
- Improvements in Vertebral Body Strength Under Teriparatide Treatment Assessed In Vivo by Finite Element Analysis: Results From the EUROFORS Study
- (2009) Christian Graeff et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated With Alendronate*
- (2009) Harald Dobnig et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis*
- (2009) Robert R Recker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: Results from the EUROFORS study
- (2009) Jan Borggrefe et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Of mice and men: divergent risks of teriparatide-induced osteosarcoma
- (2009) V. Subbiah et al. OSTEOPOROSIS INTERNATIONAL
- Bone density after teriparatide in patients with or without prior antiresorptive treatment: one-year results from the EUROFORS study*
- (2008) Helmut Minne et al. CURRENT MEDICAL RESEARCH AND OPINION
- Effects of PTH and Alendronate on Type I Collagen Isomerization in Postmenopausal Women With Osteoporosis: The PaTH Study
- (2008) Patrick Garnero et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment
- (2008) Barbara M Obermayer-Pietsch et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate
- (2008) Paul D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis
- (2008) R. Lindsay et al. OSTEOPOROSIS INTERNATIONAL
- Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis
- (2007) Steven Boonen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now